Data Bridge Market Research analyses a growth rate in the myeloid leukemia treatment market in the forecast period 2023-2030. The market is expected to reach USD 34.30 billion by 2030, which is USD 16 billion in 2022, and is expected to undergo a CAGR of 10% during the forecast period 2023 to 2030.
Comments
0 comment